A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

DSpace Repository

A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

Author: Fiedler, Walter; Kayser, Sabine; Kebenko, Maxim; Janning, Melanie; Krauter, Juergen; Schittenhelm, Marcus; Goetze, Katharina; Weber, Daniela; Goehring, Gudrun; Teleanu, Veronica; Thol, Felicitas; Heuser, Michael; Doehner, Konstanze; Ganser, Arnold; Doehner, Hartmut; Schlenk, Richard F.
Tübinger Autor(en):
Schittenhelm, Marcus Matthias
Published in: British Journal of Haematology (2015), Bd. 169, H. 5, S. 694-700
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1111/bjh.13353
ISSN: 0007-1048
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)